Global Wearable Injectors Market - Forecasts from 2019 to 2024

November 2019 | 105 pages | ID: G59EF1AD2330EN
Knowledge Sourcing Intelligence LLP

Abstracts

Global wearable injectors market is projected to grow at a CAGR of 21.20% during the forecast period, reaching a total market size of US$5.617 billion in 2024 from US$1.772 billion in 2018. Wearable injectors are also called patch pumps or patch injectors are the devices used for the delivery of drugs. The device helps to deliver the drugs in a controlled manner which is faster and safer through subcutaneous tissues. Wearable injectors are user-friendly and they reduce the need for multiple painful injections making it convenient for the patients. The growth of the market may be attributed to the increase in the incidence of cancer and diabetes and the adoption of advanced technological products. Favorable reimbursement scenario in developed countries pertaining to wearable injectors will also augment the growth of the market during the forecast period. However, preference and availability of alternative drug delivery modes might hamper the growth of the market during the given time frame.

The “Global Wearable Injectors Market– Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.

The global wearable injectors market segmented based on type, application, end-user, and geography. By type, the market has been segmented into on-body and off-body. By application, the market has been segmented into cardiovascular diseases, diabetes, Parkinson’s disease, and others. By the end-user, the market has been segmented into hospitals and clinics and home care settings.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the Global Wearable Injectors market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global wearable injectors market.

Segmentation

The global wearable injectors market has been analyzed through the following segments:

By Type

• On-Body
• Off-Body

By Application

• Cardiovascular Diseases
• Diabetes
• Parkinson’s Disease
• Others

By End User

• Hospitals and Clinics
• Home Care Settings

By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• Germany
• France
• United Kingdom
• Spain
• Others

Middle East and Africa

• Israel
• Saudi Arabia
• Others

Asia Pacific

• China
• Japan
• South Korea
• India
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Buyers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitutes
  4.5.5 Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE

5.1. On-Body
5.2. Off-Body

6. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION

6.1. Cardiovascular Diseases
6.2. Diabetes
6.3. Parkinson’s Disease
6.4. Others

7. GLOBAL WEARABLE INJECTORS MARKET BY END USER

7.1. Hospitals and Clinics
7.2. Home Care Settings

8. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. United Kingdom
  8.3.4. Spain
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Israel
  8.4.2. Saudi Arabia
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. Japan
  8.5.3. South Korea
  8.5.4. India
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. E3D Elcam Drug Delivery Devices
10.2. Subcuject ApS
10.3. BD
10.4. Enable Injections
10.5. Ypsomed AG
10.6. West Pharmaceutical Services
10.7. Unilife Corporation
10.8. Amgen
LIST OF FIGURES
LIST OF TABLES